Evidence map›Paper›PMID 23846218›Full record

ArticleCell death & disease2013

Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia.

S J Kim, Jianrong Li

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Advances inMicroorganisms · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Immunogenic necroptosis in liver diseases: mechanisms and therapeutic potential.Journal of molecular medicine (Berlin, Germany) · 2023
    Review
  17. The Z-nucleic acid sensor ZBP1 in health and disease.The Journal of experimental medicine · 2023
    Article
  18. The double-edged functions of necroptosis.Cell death & disease · 2023
    Review
  19. Necroptosis: A Pathogenic Negotiator in Human Diseases.International journal of molecular sciences · 2022
    Review
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S J KimDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843, USA.
Jianrong Li
Texas A&M University · US

Funding

Glial Interactions in Premyelinating Oligodendrocyte DestructionR01NS060017 · NINDS · TEXAS A&M UNIVERSITY · PI LI, JIANRONG · 2007 to 2010
$1.3M
Glial Interactions in Premyelinating Oligodendrocyte DestructionR56NS060017 · NINDS · TEXAS A&M UNIVERSITY · PI LI, JIANRONG · 2012 to 2012
$351k
NINDS NIH HHS NS060017NINDS NIH HHS R01 NS060017NINDS NIH HHS R56 NS060017
6 · The paper itself

Abstract

Microglia are the resident immune cells in the central nervous system and key players against pathogens and injury. However, persistent microglial activation often exacerbates pathological damage and has been implicated in many neurological diseases. Despite their pivotal physiological and pathophysiological roles, how the survival and death of activated microglia is regulated remains poorly understood. We report here that microglia activated through Toll-like receptors (TLRs) undergo RIP1/RIP3-dependent programmed necrosis (necroptosis) when exposed to the pan caspase inhibitor zVAD-fmk. Although zVAD-fmk and the caspase-8 inhibitor IETD-fmk had no effect on unstimulated primary microglia, they markedly sensitized microglia to TLR1/2,3,4,7/8 ligands or TNF treatment, triggering programmed necrosis that was completely blocked by R1P1 kinase inhibitor necrostatin-1. Interestingly, necroptosis induced by TLR ligands and zVAD was restricted to microglial cells and was not observed in astrocytes, neurons or oligodendrocytes even though they are known to express certain TLRs. Deletion of genes encoding TNF or TNFR1 failed to prevent lipopolysaccharide- and poly(I:C)-induced microglial necroptosis, unveiling a TNF-independent programmed necrosis pathway in TLR3- and TLR4-activated microglia. Microglia from mice lacking functional TRIF were fully protected against TLR3/4 activation and zVAD-fmk-induced necrosis, and genetic deletion of rip3 also prevented microglia necroptosis. Activation of c-jun N-terminal kinase and generation of specific reactive oxygen species were downstream signaling events required for microglial cell death execution. Taken together, this study reveals a robust RIP3-dependent necroptosis signaling pathway in TLR-activated microglia upon caspase blockade and suggests that TLR signaling and programmed cell death pathways are closely linked in microglia, which could contribute to neuropathology and neuroinflammation when dysregulated.

Indexed as

NecrosisAdaptor Proteins, Vesicular TransportAnimalsApoptosisAstrocytesCaspase 8Caspase InhibitorsCells, CulturedCell SurvivalCentral Nervous System DiseasesImidazolesIndolesJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMiceMice, 129 StrainAdaptor Proteins, Vesicular Transportbenzyloxycarbonyl-valyl-alanyl-aspartic acidCasp8 protein, mouseCaspase 8Caspase InhibitorsImidazolesIndolesJNK Mitogen-Activated Protein KinasesLipopolysaccharidesnecrostatin-1OligopeptidesReactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseRipk3 protein, mouseTicam1 protein, mouseToll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID23846218
PMCPMC3730412
OpenAlexW2057842355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.